CN103142966A - Medicament for wound healing - Google Patents
Medicament for wound healing Download PDFInfo
- Publication number
- CN103142966A CN103142966A CN201310099421XA CN201310099421A CN103142966A CN 103142966 A CN103142966 A CN 103142966A CN 201310099421X A CN201310099421X A CN 201310099421XA CN 201310099421 A CN201310099421 A CN 201310099421A CN 103142966 A CN103142966 A CN 103142966A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- medicament
- radix
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a medicament for wound healing. The medicament is prepared from the following substances in percentage by weight: 5-10 parts of figwort, 10-20 parts of dried ginger, 20-30 parts of cornel, 10-20 parts of platycodon grandiflorum, 15-25 parts of coptis chinensis, 5-15 parts of chrysanthemum, 10-30 parts of golden-rod, 1-15 parts of henbane, 10-20 parts of Chinese ephedra, 15-30 parts of pyrrosia lingua, 20-30 parts of tabasheer, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of rhizoma imperatae, 10-30 parts of cocklebur fruit, 1-20 parts of radix rubiae, 15-20 parts of common jasminorange, 10-20 parts of semen pharbitidis, 15-20 parts of inula, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of spina date seed, 1-20 parts of uniflower swisscentaury root, 15-25 parts of potentilla discolor, 10-20 parts of franchet groundcherry calyx, 15-25 parts of cortex mori radicis, 20-30 parts of lindley eupatorium, 1-20 parts of nodus nelumbinis rhizomatis and 10-25 parts of Chinese azalea flower. As all components of medicament for wound healing are natural materials, the medicament has good safety and exact curative effect and is suitable for large-scale popularization.
Description
Technical field
The present invention relates to the nursing in operating room field, relate in particular to a kind of medicament for wound healing.
Background technology
If injure outward surgical wound surface deal with improperly can occur that wound surface is hemorrhage, infection, pain, healing time are long, vital tissue such as tendon, nerve, exposed bone and cicatrix hyperplasia etc., cause very large misery to the patient, also bring a lot of difficulties to clinical treatment simultaneously.Clinical wound surface processing method commonly used comprises physiotherapy (as microwave, infrared ray, laser etc.), wet packing of drugs, nano silver antibiotic dressing, somatomedin etc. a few days ago, there are many deficiencies in these Therapeutic Method, as not obvious in pigmentation, drug allergy, curative effect etc., all effectively wound healing and complication.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for wound healing.
in order to realize purpose of the present invention, the invention provides a kind of medicament for wound healing, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Concretio Silicea Bambusae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Radix Rubiae 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Semen Ziziphi Spinosae 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Nodus Nelumbinis Rhizomatis 1-20 part and Flos Rhododendri Mollis 10-25 part.
preferably, medicament for wound healing of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Concretio Silicea Bambusaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts, Radix Rubiae, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Semen Ziziphi Spinosaes, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Nodus Nelumbinis Rhizomatis and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for wound healing of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, is suitable for large-scale promotion clinically.
The specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, Rhizoma Coptidis 21 grams, Flos Chrysanthemi 13 grams, Herba Solidaginis 28 grams, Semen Hyoscyami 11 grams, Herba Ephedrae 17 grams, Folium Pyrrosiae 24 grams, Concretio Silicea Bambusae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Xanthii 21 grams, Radix Rubiae 16 grams, Folium Et Cacumen Murrayae 16 grams, Semen Pharbitidis 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Semen Ziziphi Spinosae 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Nodus Nelumbinis Rhizomatis 16 grams and Flos Rhododendri Mollis 24 grams, add 4172 milliliters of entry, in being housed, heated 5.5 hours under 74 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 850 milliliters, namely gets decoction of the present invention.
Experimental example
Physical data
Trauma patient 960 examples, male 455 examples, female's 505 examples, age 21-59 (average 38.5) year, starting traumatic injury wound surface 324 examples wherein, pressure ulcer 258 examples, operation wound 139 examples, recurrent wound 119 examples, other reasons person 120 examples, the course of disease are generally 2d-4w (average 2.4w.The equal informed consent of patient.Be divided into treatment group 486 example and matched group 474 examples, between group, the differences with insignificance such as sex, age, the state of an illness, the course of disease, have comparability.
Therapeutic Method
Treatment group: to emergency treatment wound and other wound surface in refractory to treatment, at first remove the local necrosis tissue, then use iodophor disinfection liquid disinfectant wound surface, the decoction for preparing in oral embodiment 1 after sterilization is treated, and every day 3 times, each oral 200 milliliters, treats 7 days.Matched group: at first remove the local necrosis tissue, then use iodophor disinfection liquid disinfectant wound surface, make the local exposure of wound surface after sterilization, by infrared equipment (Shijiazhuang three medical apparatus and instruments company limited difficult to understand) irradiation wound surface, smear simultaneously Soviet Union's skin gel (medical chitosan wound repair gel, Wuhan greatly just high section biological medicine company limited), every day 2 times, each wound surface coating 20 grams were treated 7 days.Observe the patient during treatment and have or not infection and other untoward reaction, adopt blind method to carry out the healing state evaluation, and according to efficacy assessment standard, therapeutic effect is analyzed.
Efficacy assessment standard
Recovery from illness: wound healing, form a scab and come off; Take a turn for the better: transudate reduces, and wound surface dwindles area>20%, and the degree of depth shoals, without secretions, and the granulation tissue growth; Invalid: wound surface area and the degree of depth are without change.Effectively=recovery from illness+take a turn for the better.
Result
Treatment group recovery from illness 432 examples, take a turn for the better 54 examples, invalid 0 example, total effective rate 100.0%; Matched group recovery from illness 89 examples, take a turn for the better 161 examples, invalid 224 examples, total effective rate 52.7%.The total effective rate for the treatment of group is apparently higher than the total effective rate of matched group.During medication, the treatment group patient has no untoward reaction, also not recurrence after healing.Matched group is found 3 routine infection events during treating.
Claims (3)
1. medicament that is used for wound healing, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Concretio Silicea Bambusae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Radix Rubiae 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Semen Ziziphi Spinosae 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Nodus Nelumbinis Rhizomatis 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for wound healing according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Concretio Silicea Bambusaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts, Radix Rubiae, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Semen Ziziphi Spinosaes, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Nodus Nelumbinis Rhizomatis and Flos Rhododendri Mollis.
3. the medicament for wound healing according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310099421XA CN103142966A (en) | 2013-03-27 | 2013-03-27 | Medicament for wound healing |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310099421XA CN103142966A (en) | 2013-03-27 | 2013-03-27 | Medicament for wound healing |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103142966A true CN103142966A (en) | 2013-06-12 |
Family
ID=48541475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310099421XA Pending CN103142966A (en) | 2013-03-27 | 2013-03-27 | Medicament for wound healing |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103142966A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550327A (en) * | 2013-11-01 | 2014-02-05 | 刘增慧 | Preparation method of medicament for healing of wound |
CN105031255A (en) * | 2015-07-12 | 2015-11-11 | 姚静 | Traditional Chinese medicine preparation for abdominal trauma nursing and its preparation method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1304731A (en) * | 2000-01-06 | 2001-07-25 | 王乃正 | Exterior-applied Chinese patent medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
-
2013
- 2013-03-27 CN CN201310099421XA patent/CN103142966A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1304731A (en) * | 2000-01-06 | 2001-07-25 | 王乃正 | Exterior-applied Chinese patent medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
Non-Patent Citations (2)
Title |
---|
李恒山等: "创口闭合汤治疗创口延迟愈合486例", 《吉林中医药》 * |
肖伟等: "试论创伤肿痛从气滞、血瘀、寒凝论治", 《中医药导报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103550327A (en) * | 2013-11-01 | 2014-02-05 | 刘增慧 | Preparation method of medicament for healing of wound |
CN105031255A (en) * | 2015-07-12 | 2015-11-11 | 姚静 | Traditional Chinese medicine preparation for abdominal trauma nursing and its preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102283969A (en) | Ointment for pressure sores | |
CN101780157B (en) | Ointment for treating bedsore and preparation method thereof | |
CN103142966A (en) | Medicament for wound healing | |
CN103285332A (en) | Pharmaceutical composition for promoting post-operation wound healing | |
CN103550327A (en) | Preparation method of medicament for healing of wound | |
CN101607017A (en) | A kind of oral Chinese medicine for the treatment of fracture | |
CN103142981A (en) | Medicament for treating mammitis | |
CN103142987A (en) | Medicament for treating mumps | |
CN103007240A (en) | Medicament for aged wound healing | |
CN102920824B (en) | Liniment for treating bedsore and preparation method thereof | |
CN102178843A (en) | Chinese medicinal powder for treating dental ulcer and stomatitis | |
CN101849992A (en) | Medicament for treating inferior turbinate hypertrophy and method for preparing same | |
CN1210000A (en) | Ointment for wounds and sores and preparation thereof | |
CN100562324C (en) | A kind of medicine for the treatment of burn, scalding and preparation method thereof | |
CN101274047B (en) | External-use ointment for treating burn and method of preparing the same | |
CN103142958A (en) | Medicament for treating perniosis | |
CN106109854A (en) | A kind of pharmaceutical composition promoting skin wound healing | |
CN103417680B (en) | Externally-applied Chinese medicine for treating burn and scald and preparation method of same | |
CN102813828B (en) | Stropanthus divericatus for treating external wounds | |
CN102302595A (en) | Liquid medicine for treating burn | |
CN106511770A (en) | Traditional Chinese medicine preparation treating herpes zoster and preparing method of traditional Chinese medicine preparation | |
CN102908392B (en) | External Chinese herbal preparation for treating nasal polyp and preparation method | |
CN103142984B (en) | Medicine for treating rheumatism | |
CN103142960B (en) | Medicament for treating skin diseases | |
CN103157085A (en) | Drug for treating fracture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130612 |